195 related articles for article (PubMed ID: 16468416)
1. Pharmacogenomics and clinical biomarkers in drug discovery and development.
Ross JS; Symmans WF; Pusztai L; Hortobagyi GN
Am J Clin Pathol; 2005 Dec; 124 Suppl():S29-41. PubMed ID: 16468416
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics.
Ross JS; Schenkein DP; Kashala O; Linette GP; Stec J; Symmans WF; Pusztai L; Hortobagyi GN
Adv Anat Pathol; 2004 Jul; 11(4):211-20. PubMed ID: 15220824
[TBL] [Abstract][Full Text] [Related]
3. Expression genomics and drug development: towards predictive pharmacology.
Liu ET
Brief Funct Genomic Proteomic; 2005 Feb; 3(4):303-21. PubMed ID: 15814022
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. Molecular profiling approaches for identifying novel biomarkers.
Bailey WJ; Ulrich R
Expert Opin Drug Saf; 2004 Mar; 3(2):137-51. PubMed ID: 15006720
[TBL] [Abstract][Full Text] [Related]
6. The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics.
Ferrer-Alcón M; Arteta D; Guerrero MJ; Fernandez-Orth D; Simón L; Martinez A
Toxicol Lett; 2009 Apr; 186(1):45-51. PubMed ID: 19022361
[TBL] [Abstract][Full Text] [Related]
7. Personalised medicine for cancer: from drug development into clinical practice.
Jain KK
Expert Opin Pharmacother; 2005 Aug; 6(9):1463-76. PubMed ID: 16086635
[TBL] [Abstract][Full Text] [Related]
8. How molecular profiling could revolutionize drug discovery.
Stoughton RB; Friend SH
Nat Rev Drug Discov; 2005 Apr; 4(4):345-50. PubMed ID: 15789121
[TBL] [Abstract][Full Text] [Related]
9. [Toxicogenomics--a new paradigm of toxicology and birth of reverse toxicology].
Hirabayashi Y; Inoue T
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2002; (120):39-52. PubMed ID: 12638183
[TBL] [Abstract][Full Text] [Related]
10. Alternative strategies in drug development: clinical pharmacological aspects.
Kuhlmann J
Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
[TBL] [Abstract][Full Text] [Related]
11. Challenges of drug discovery for personalized medicine.
Jain KK
Curr Opin Mol Ther; 2006 Dec; 8(6):487-92. PubMed ID: 17243483
[TBL] [Abstract][Full Text] [Related]
12. Reducing false positive findings in statistical analysis of pharmacogenomic biomarker studies using high-throughput technologies.
Matsui S
Curr Drug Saf; 2006 May; 1(2):135-41. PubMed ID: 18690924
[TBL] [Abstract][Full Text] [Related]
13. Integration of molecular diagnostics with therapeutics: implications for drug discovery and patient care.
Ross JS; Ginsburg GS
Expert Rev Mol Diagn; 2002 Nov; 2(6):531-41. PubMed ID: 12465450
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
Yan L; Beckman RA
Biotechniques; 2005 Oct; 39(4):565-8. PubMed ID: 16235569
[TBL] [Abstract][Full Text] [Related]
15. Improving the prediction of chemotherapeutic sensitivity of tumors in breast cancer via optimizing the selection of candidate genes.
Jiang L; Huang L; Kuang Q; Zhang J; Li M; Wen Z; He L
Comput Biol Chem; 2014 Apr; 49():71-8. PubMed ID: 24440656
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics and breast cancer management: current status and perspectives.
Ciccolini J; Fanciullino R; Serdjebi C; Milano G
Expert Opin Drug Metab Toxicol; 2015 May; 11(5):719-29. PubMed ID: 25690018
[TBL] [Abstract][Full Text] [Related]
17. Advances in pharmacogenomics technologies.
Bhasker CR; Hardiman G
Pharmacogenomics; 2010 Apr; 11(4):481-5. PubMed ID: 20350126
[TBL] [Abstract][Full Text] [Related]
18. Pharmacoproteomics: a chess game on a protein field.
D'Alessandro A; Zolla L
Drug Discov Today; 2010 Dec; 15(23-24):1015-23. PubMed ID: 20969973
[TBL] [Abstract][Full Text] [Related]
19. Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential.
Clarke PA; te Poele R; Wooster R; Workman P
Biochem Pharmacol; 2001 Nov; 62(10):1311-36. PubMed ID: 11709192
[TBL] [Abstract][Full Text] [Related]
20. Metabolic profiling technologies for biomarker discovery in biomedicine and drug development.
Schlotterbeck G; Ross A; Dieterle F; Senn H
Pharmacogenomics; 2006 Oct; 7(7):1055-75. PubMed ID: 17054416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
